Cargando…

1467. Breakthrough Omicron Infections in Booster Vaccinated Healthcare Workers

BACKGROUND: There are few data on immune correlation of protection from breakthrough Omicron (B.1.1.529) infection in individuals who received booster vaccines. We thus compared a neutralizing antibody titers against Omicron within the first month after the mRNA booster at the time before omicron wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jeongjae, Park, Soonju, Kim, Ji Yeon, Lim, So Yun, Bae, SeongMan, Jung, Jiwon, Jae Kim, Min, Chong, Yong Pil, Choi, Sang-Ho, Lee, Sang-Oh, Kim, Yang Soo, Lee, Nakyung, Kim, Kideok, Shum, David, Jee, Yongmee, Kim, Sung-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751915/ http://dx.doi.org/10.1093/ofid/ofac492.1294

Ejemplares similares

No correlation of neutralizing antibody titers against the Omicron variant after a booster dose of COVID-19 vaccines with subsequent breakthrough Omicron infections among healthcare workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Breakthrough infections and waning immune responses with ChAdOx1 nCoV‐19 or mRNA vaccine in healthcare workers
por: Lim, So Yun, et al.
Publicado: (2022)

Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination
por: Lim, So Yun, et al.
Publicado: (2021)

Comparison of the clinical and virological characteristics of SARS-CoV-2 Omicron BA.1/BA.2 and omicron BA.5 variants: A prospective cohort study
por: Kang, Sung-Woon, et al.
Publicado: (2023)

Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 Vaccines
por: Kim, Ji Yeun, et al.
Publicado: (2021)

Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
por: Kim, A Reum, et al.
Publicado: (2023)

259. Comparison of the causes of death in patients with delta variant versus omicron variant infections
por: Reum Kim, A, et al.
Publicado: (2022)

Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

Correction to: Protracted course of SARS‑CoV‑2 pneumonia in moderately to severely immunocompromised patients
por: Lee, Jeongjae, et al.
Publicado: (2023)

Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19
por: Kim, Dong-In, et al.
Publicado: (2022)

288. Analysis of serum antibody response as correlates of protection against SARS-CoV-2 infection and the effects of BA.4/5 bivalent booster vaccination
por: Yun Lim, So, et al.
Publicado: (2023)

785. Bacterial Co-infection and Empirical Antibiotic Therapy in Patients with COVID-19
por: Lee, Jiyoung, et al.
Publicado: (2022)

Risk Factors for Mortality in Patients with Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae and Escherichia coli bacteremia
por: Seo, Hyeonji, et al.
Publicado: (2021)

Bacterial Co-Infection and Empirical Antibacterial Therapy in Patients With COVID-19
por: Lee, Jiyoung, et al.
Publicado: (2023)

61. Short- versus prolonged-courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection
por: Bae, Moonsuk, et al.
Publicado: (2021)

Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study
por: Bae, Seongman, et al.
Publicado: (2021)

Clinical characteristics of COVID-19 rebound after nirmatrelvir-ritonavir or molnupiravir therapy: A prospective cohort study
por: Han, Jaijun, et al.
Publicado: (2023)

R1467H Variants of Rho Guanine Nucleotide Exchange Factor 11 (ARHGEF11) are Associated with Type 2 Diabetes Mellitus in Koreans
por: Jin, Qing Song, et al.
Publicado: (2010)

515. The Impact of Prolonged Steroid Use on Critically Ill COVID-19 Patients: A Retrospective Cohort Study
por: Han, Jaijun, et al.
Publicado: (2023)

Changing characteristics of S. aureus bacteremia caused by PVL-negative, MRSA strain over 11 years
por: Yang, Eunmi, et al.
Publicado: (2021)

Clinical and Microbiological Characteristics of Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Bacteremia Caused by a Community-Associated PVL-Negative Strain
por: Lee, Yun Woo, et al.
Publicado: (2021)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

411. Comparison of clinical outcomes between early and delayed transplantation after SARS-CoV-2 infection
por: Reum Kim, A, et al.
Publicado: (2023)

Immune Response Kinetics Following a Third Heterologous BNT162b2 Booster Dose After Primary 2-Dose ChAdOx1 Vaccination in Relation to Omicron Breakthrough Infection: A Prospective Nationwide Cohort Study in South Korea
por: Ahn, Jin Young, et al.
Publicado: (2023)

Molecular Characteristics and Prevalence of Rifampin Resistance in Staphylococcus aureus Isolates from Patients with Bacteremia in South Korea
por: Kim, Yong Kyun, et al.
Publicado: (2023)

1082. Clinical Characteristics and Vertical Transmission of Pregnant Women with SARS-CoV-2 Infection and Their Neonates
por: Lee, Jiyoung, et al.
Publicado: (2022)

929. The different characteristics in renal impairment between severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome in South Korea
por: Ra, Sang Hyun, et al.
Publicado: (2023)

1357. Initial and Peak Serum Levels of Krebs von den Lungen-6 for Prediction of Prognosis in Patients with COVID-19
por: Kim, Geonui, et al.
Publicado: (2023)

In Vitro Activities of Ceftazidime–Avibactam and Aztreonam–Avibactam at Different Inoculum Sizes of Extended-Spectrum β-Lactam-Resistant Enterobacterales Blood Isolates
por: Bae, Moonsuk, et al.
Publicado: (2021)

A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection
por: Kim, Heui Man, et al.
Publicado: (2023)

Clinical Sensitivity of the (1–3)-β-D-glucan Test for Predicting Candidemia
por: Lee, Yun Woo, et al.
Publicado: (2023)

Kinetics of Glycoprotein-Specific Antibody Response in Patients with Severe Fever with Thrombocytopenia Syndrome
por: Chung, Hyemin, et al.
Publicado: (2022)

1467 Delaying Diagnostic Procedure Significantly Increases Mortality in Patients with Invasive Mucormycosis
por: Lee, Ji Un, et al.
Publicado: (2014)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
por: Möhlendick, Birte, et al.
Publicado: (2022)

Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections
por: Yang, Jinyoung, et al.
Publicado: (2023)

Daily, self-test rapid antigen test to assess SARS-CoV-2 viability in de-isolation of patients with COVID-19
por: Bae, Seongman, et al.
Publicado: (2022)

Risk and Outcome of Infective Endocarditis in Streptococcal Bloodstream Infections according to Streptococcal Species
por: Seo, Hyeonji, et al.
Publicado: (2023)

Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection
por: Kang, Sung Woon, et al.
Publicado: (2022)

Corrigendum to “Comparison of outward transmission potential between vaccinated and partially vaccinated or unvaccinated individuals with the SARS-CoV-2 delta variant infection” [J Infect 85 (2022) e69–e71]
por: Kang, Sung Woon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l0akrgp22r5g4jg55l5oa654q3